Ordinary Adjustment | Solactive G2 Healthcare 50 Select Index | Effective Date 25th September 2025
Solactive G2 Healthcare 50 Select Index:
In the ordinary adjustment, the following composition will be implemented effective open 25th September 2025:
3SBIO INC |
ABBOTT LABORATORIES |
ABBVIE INC |
AKESO INC |
AMGEN INC |
ASCENTAGE PHARMA GROUP INTERNATIONAL |
BEIGENE LTD |
BOSTON SCIENTIFIC CORP |
BRISTOL-MYERS SQUIBB CO |
CHINA MEDICAL SYSTEM HOLDINGS LTD |
CHINA RESOURCES PHARMACEUTICAL |
CSPC PHARMACEUTICAL GROUP LTD |
DANAHER CORP |
DUALITYBIO-B ORD |
ELEVANCE HEALTH INC |
ELI LILLY & CO |
EVEREST MEDICINES LTD |
GENSCRIPT BIOTECH CORP |
GILEAD SCIENCES INC |
GRAND PHARMACEUTICAL GROUP LTD |
HANSOH PHARMACEUTICAL GROUP CO |
HCA HEALTHCARE INC |
HENGRUI PHARMA ORD H |
HUTCHMED CHINA LTD |
INNOCARE PHARMA LTD |
INNOVENT BIOLOGICS INC |
INTUITIVE SURGICAL INC |
JOHNSON & JOHNSON |
KEYMED BIOSCIENCES INC |
MEDTRONIC PLC |
MERCK & CO. INC. |
MICROPORT SCIENTIFIC CORP |
PFIZER INC |
QUANTUMPHARM INC |
REMEGEN CO LTD-H |
SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD |
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD |
SHANGHAI MICROPORT MEDBOT GR |
SIMCERE PHARMACEUTICAL GROUP |
SINO BIOPHARMACEUTICAL LTD ORD |
SKB BIO-B ORD H |
STRYKER CORP |
THERMO FISHER SCIENTIFIC INC |
UNITED LABORATORIES INTERNATIONAL HOLDINGS LTD. |
UNITEDHEALTH GROUP INC |
VERTEX PHARMACEUTICALS INC |
WUXI APPTEC CO LTD |
WUXI BIOLOGICS CAYMAN INC |
ZAI LAB LTD |
ZOETIS INC |